Practice
Hong Kong and US IPOs.
Nine completed listings, most of them life science and hard tech.
9*listings completed
Life scienceincluding Chapter 18A
Hard techincluding Chapter 18C
Sizes are given as ranges; years and roles are as filed. Further mandates in progress are not listed.
Life science
- Over HK$1.5bn
2025 · Underwriter counselA clinical-stage biotech company listed under Chapter 18A, the largest such offering in four years. Counsel to the underwriters, from due diligence and underwriting agreement negotiations through to closing.
- Over HK$700m
2025 · Company counselA late-stage biopharma whose first product is now commercialised, listed under Chapter 18A. Counsel to the issuer: drafting the prospectus, answering HKEX comments and negotiating the underwriting agreement.
- Over HK$300m
2024 · Underwriter counselA leading life-science software and data platform, listed under Chapter 8.05. Counsel to the underwriters, from due diligence and underwriting agreement negotiations through to closing.
- Over HK$300m
2023 · Company counselA clinical-stage biotech company listed under Chapter 18A. Counsel to the issuer: drafting the prospectus, answering HKEX comments and negotiating the underwriting agreement.
Hard tech
- Over US$300m
2026 · Underwriter counselA leading computing-technology group, listed under Chapter 8.05. Counsel to the underwriters, from due diligence and underwriting agreement negotiations through to closing.
- Over US$150m
2025 · Company counselA leading autonomous-driving technology company, listed under Chapter 8.05. Counsel to the issuer: drafting the prospectus, answering HKEX comments and negotiating the underwriting agreement.
- Over HK$1bn
2025 · Underwriter counselA leading lithium-ion power and storage battery manufacturer, listed under Chapter 8.05. Counsel to the underwriters, from due diligence and underwriting agreement negotiations through to closing.
Consumer and media
- Over HK$700m
2025 · Company counselA leading premium baby-products company, listed under Chapter 8.05. Counsel to the issuer: drafting the prospectus, answering HKEX comments and negotiating the underwriting agreement.
- Over HK$350m
2022 · Company counselA leading variety-programme producer and IP operator, listed under Chapter 8.05. Counsel to the issuer: drafting the prospectus, answering HKEX comments and negotiating the underwriting agreement.